GCA Therapeutics

GCA Therapeutics Ltd. (GCAT) is a U.S.-based specialty pharmaceutical company focused on the licensing, acquisition, and marketing of mid-to-late stage drug candidates and technologies in North America and the European Union. GCAT applies its expertise and resources to the preclinical, clinical, and final regulatory review and approval stages to commercialize products for the Chinese market. GCAT is currently in discussions with several U.S. and European biotech and pharmaceutical companies to bring multiple drugs and devices to market through its joint ventures in China. Initially, GCAT will market its products through third-party distribution partnerships and plans to establish or acquire manufacturing capabilities in China in the future.